Adma Biologics Inc Reports Results For The Quarter Ended In September: Earnings Summary

ADMA Biologics

09/11/2022 22:02

* ADMA Biologics Inc  ADMA.OQ  reported a quarterly adjusted
loss
of 8 cents​​ per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 8 cents per share.
    * Revenue rose 98.7% to $41.09 million from a year ago;
analysts
expected $34.48 million. 
    * ADMA Biologics Inc's reported EPS for the quarter was a
loss
of 8 cents​.
    * The mean earnings estimate of analysts had fallen by
about 10.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * ADMA Biologics Inc shares had risen by 7.4% this
quarter and
gained 85.1% so far this year.
    * The company reported a quarterly loss of $14.9 million.
    * Wall Street's median 12-month price target for ADMA
Biologics
Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
9 at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.08          -0.08          Met
 Jun. 30 2022      -0.08          -0.07          Beat
 Mar. 31 2022      -0.08          -0.10          Missed
 Dec. 31 2021      -0.09          -0.09          Met